Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brinzolamide/brimonidine fixed-combination versus concomitant separate drops in open-angle glaucoma or ocular hypertension
NL-OMON36182Phase 3Active, not recruiting
- Sponsor
- Alcon Inc.
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of brinzolamide and brimonidine in open-angle glaucoma (OAG) and ocular hypertension (2 arms), sponsored by Alcon Inc. Started Aug 2011; status: active, not recruiting.
02
Drugs
brinzolamidebrimonidine
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NL-OMON36182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36182.